Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Screening|May 1, 2015
Acoustic Liquid Handling for Rapid siRNA Transfection OptimizationAndrew S Xiao, Eric S Lightcap, David C Bouck
The International Journal of Biochemistry & Cell Biology|April 4, 2003
Purification and inactivation of 3-hydroxyanthranilic acid 3,4-dioxygenase from beef liverDhirendra Nandi, Eric S Lightcap, Yumee Kim Koo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2002
Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341James A Fleming, Eric S Lightcap, Seth Sadis, et al.
Molecular & Cellular Proteomics : MCP|August 30, 2011
Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924Hua Liao, Xiaozhen J Liu, Jonathan L Blank, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesisTobias Schmelzle, Arnaud A Mailleux, Michael Overholtzer, et al.
Science Signaling|March 8, 2012
Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2Devin T Worster, Tobias Schmelzle, Nicole L Solimini, et al.
Cancer Research|October 27, 2012
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924Jonathan L Blank, Xiaozhen J Liu, Katherine Cosmopoulos, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E Stokes, Veronica Calvo, Sho Fujisawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
MYC regulation of a "poor-prognosis" metastatic cancer cell stateAnita Wolfer, Ben S Wittner, Daniel Irimia, et al.
Pageof 2